Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Crane

Showing results (251-260 of 301) with videos related to

Pageof 31
Sort By:
Cancer Medicine|August 29, 2018
Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinomaDalia Elganainy, Emma B Holliday, Cullen M Taniguchi, et al.
International Journal of Radiation Oncology, Biology, Physics|June 4, 2018
Differential Association Between Circulating Lymphocyte Populations With Outcome After Radiation Therapy in Subtypes of Liver CancerClemens Grassberger, Theodore S Hong, Tai Hato, et al.
International Journal of Cancer|November 25, 2014
Adjuvant chemotherapy in rectal cancer: defining subgroups who may benefit after neoadjuvant chemoradiation and resection: a pooled analysis of 3,313 patientsMonique Maas, Patty J Nelemans, Vincenzo Valentini, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 19, 2013
Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survivalChing-Wei D Tzeng, Hop S Tran Cao, Jeffrey E Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|October 3, 2006
Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancerSunil Krishnan, Nora A Janjan, John M Skibber, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2025
Development of Second Malignancies Following Chemotherapy With or Without Radiation Therapy for the Treatment of Locally Advanced Rectal CancerKathryn R Tringale, Kush H Patel, Lara Hilal, et al.
Plos One|June 24, 2016
Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic CancerAwalpreet S Chadha, Heath D Skinner, Jillian R Gunther, et al.
International Journal of Radiation Oncology, Biology, Physics|August 20, 2023
Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848Leila T Tchelebi, Kathryn A Winter, Ross A Abrams, et al.
American Journal of Clinical Oncology|November 22, 2022
Use of the Toxicity Index in Evaluating Adverse Events in Anal Cancer Trials: Analysis of RTOG 9811 and RTOG 0529Jordan R Kharofa, Greg Yothers, Lisa A Kachnic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2023
Genomic Biomarkers Associated with Response to Induction Chemotherapy in Patients with Localized Pancreatic Ductal AdenocarcinomaBrett L Ecker, Alice J Tao, Quisette P Janssen, et al.
Pageof 31

Showing results (251-260 of 301) with videos related to

Sort By:
Pageof 31
Cancer Medicine|August 29, 2018
Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinomaDalia Elganainy, Emma B Holliday, Cullen M Taniguchi, et al.
International Journal of Radiation Oncology, Biology, Physics|June 4, 2018
Differential Association Between Circulating Lymphocyte Populations With Outcome After Radiation Therapy in Subtypes of Liver CancerClemens Grassberger, Theodore S Hong, Tai Hato, et al.
International Journal of Cancer|November 25, 2014
Adjuvant chemotherapy in rectal cancer: defining subgroups who may benefit after neoadjuvant chemoradiation and resection: a pooled analysis of 3,313 patientsMonique Maas, Patty J Nelemans, Vincenzo Valentini, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 19, 2013
Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survivalChing-Wei D Tzeng, Hop S Tran Cao, Jeffrey E Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|October 3, 2006
Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancerSunil Krishnan, Nora A Janjan, John M Skibber, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2025
Development of Second Malignancies Following Chemotherapy With or Without Radiation Therapy for the Treatment of Locally Advanced Rectal CancerKathryn R Tringale, Kush H Patel, Lara Hilal, et al.
Plos One|June 24, 2016
Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic CancerAwalpreet S Chadha, Heath D Skinner, Jillian R Gunther, et al.
International Journal of Radiation Oncology, Biology, Physics|August 20, 2023
Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848Leila T Tchelebi, Kathryn A Winter, Ross A Abrams, et al.
American Journal of Clinical Oncology|November 22, 2022
Use of the Toxicity Index in Evaluating Adverse Events in Anal Cancer Trials: Analysis of RTOG 9811 and RTOG 0529Jordan R Kharofa, Greg Yothers, Lisa A Kachnic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2023
Genomic Biomarkers Associated with Response to Induction Chemotherapy in Patients with Localized Pancreatic Ductal AdenocarcinomaBrett L Ecker, Alice J Tao, Quisette P Janssen, et al.
Pageof 31